This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
Q4 Earnings for J&J, Procter, GE & More
by Mark Vickery
Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
P&G (PG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for P&G (PG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Procter & Gamble (PG) Q2 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 8.24% and 0.49%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Bulls Dominate as Economic Goldilocks Scenario Pushes Equities Into the Nosebleed Section
by Mayur Thaker
...however, underlying leading economic indicators continue to diverge from equity p/e multiples.
The Zacks Analyst Blog Highlights Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific
by Zacks Equity Research
Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific are included in this Analyst Blog.
Top Research Reports for Microsoft, Procter & Gamble & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company (PG) and AstraZeneca PLC (AZN).
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Zacks Investment Ideas feature highlights: Microsoft, Procter & Gamble and United Rentals
by Zacks Equity Research
Microsoft, Procter & Gamble and United Rentals have been highlighted in this Investment Ideas article.
Countdown to P&G (PG) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
3 Large-Cap Stocks to Buy Before Earnings and Hold Forever
by Benjamin Rains
Investors who can handle the near-term uncertainty that earnings season brings might want to consider buying these three large-cap stocks ahead of their upcoming releases and holding them for the long haul...
Is a Surprise Coming for Procter & Gamble (PG) This Earnings Season?
by Zacks Equity Research
Procter & Gamble (PG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
The Zacks Analyst Blog Highlights Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers
by Zacks Equity Research
Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers are included in this Analyst Blog.
5 Blue-Chip Stocks to Buy Ahead of Earnings Results
by Nalak Das
We have narrowed our search to five Dow stocks that are poised to beat on earnings results. These are: AAPL, KO, BA, PG, TRV.
Here's Why Procter & Gamble (PG) Fell More Than Broader Market
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $149.79, representing a -0.54% change from its previous close.
Procter & Gamble (PG) Strong Brands Aid Growth Amid Inflation
by Zacks Equity Research
Procter & Gamble (PG) is navigating market challenges and leveraging growth opportunities in fiscal 2024, showcasing robust sales in key divisions and innovative ventures like Ninjamas.
Procter & Gamble (PG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will P&G (PG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Heineken (HEINY) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Heineken NV (HEINY) and Procter & Gamble (PG) have performed compared to their sector so far this year.
Procter & Gamble (PG) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $148.69 in the latest trading session, marking a +0.86% move from the prior day.